In prostate cancer cells, β-catenin also forms a transcription repressing complex to suppress NF-κB, resulting in downregulation of metastasis suppressor KAI1, a NFκB target gene (Kim et al., 2005) (Figure 7). The gene discussed is NFKB1; the disease is prostate cancer.